Novo Nordisk ADR (NYSE: NVO) is -8.22% lower on its value in year-to-date trading and has touched a low of $77.82 and a high of $148.15 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The NVO stock was last observed hovering at around $87.17 in the last trading session, with the day’s loss setting it -8.22%.
Currently trading at $78.95, the stock is -8.01% and -7.30% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 12.59 million and changing -9.43% at the moment leaves the stock -31.51% off its SMA200. NVO registered -36.71% loss for a year compared to 6-month loss of -39.68%.
The stock witnessed a -9.43% gain in the last 1 month and extending the period to 3 months gives it a -27.55%, and is -11.66% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 2.38% over the week and 2.37% over the month.
Novo Nordisk ADR (NVO) has around 76302 employees, a market worth around $265.60B and $42.09B in sales. Current P/E ratio is 24.05 and Fwd P/E is 16.50. Profit margin for the company is 34.81%. Distance from 52-week low is 1.45% and -46.71% from its 52-week high. The company has generated returns on investments over the last 12 months (45.25%).
with sales reaching $81.83B over the same period.The EPS is expected to grow by 22.35% this year, but quarterly earnings will post 21.41% year-over-year. Quarterly sales are estimated to grow 25.22% in year-over-year returns.
Novo Nordisk ADR (NVO) Top Institutional Holders
The shares outstanding are 3.37B, and float is at 3.36B with Short Float at 0.40%.
The top institutional shareholder in the company is JENNISON ASSOCIATES LLC with over 21.22 million shares valued at $3.03 billion. The investor’s holdings represent 0.476% of the NVO Shares outstanding. As of 2024-06-30, the second largest holder is FMR LLC with 19.49 million shares valued at $2.78 billion to account for 0.4371 of the shares outstanding. The other top investors are MORGAN STANLEY which holds 14.61 million shares representing 0.3276% and valued at over $2.09 billion, while BANK OF AMERICA CORP /DE/ holds 0.3182 of the shares totaling 14.19 million with a market value of $2.03 billion.
Novo Nordisk ADR (NVO) Insider Activity
#####
